Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1758921000168114 | bupivacaine hydrochloride monohydrate 20 mg / 4 mL + glucose monohydrate 320 mg / 4 mL injection, 5 x 4 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1758931000168112 | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, 5 x 4 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, 5 x 4 mL ampoules | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, 5 x 4 mL ampoules | Is a | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) injection, 5 x 4 mL ampoules | false | Inferred relationship | Some | ||
| bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, 5 x 4 mL ampoules | has MPUU | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, ampoule | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Marcain Spinal Heavy injection, 5 x 4 mL ampoules | Is a | False | bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL injection, 5 x 4 mL ampoules | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR